Solazyme's 100% algal derived advanced biofuel powers naval fleet
ship and outboard engines
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--
Inc. (NASDAQ:SZYM), a renewable oil and bioproducts company,
announced today that the USS Ford, a U.S. Navy Frigate fleet ship,
successfully journeyed from its homeport in Everett, WA to San Diego, CA
using Soladiesel HRD-76®, Solazyme's 100% algal
derived renewable marine diesel fuel. The voyage was fueled using 25,000
gallons of a 50/50 blend using Soladiesel® and petroleum F-76 in the
ship's LM 2500 diesel turbines, and marks the first demonstration of the
alternative fuel blend in an operational fleet ship.
Meeting the secretary of the Navy's call for a drop-in fuel replacement,
no changes were required to the infrastructure of the ship or fueling
pier for the test. Feedback from the ship's engineers was favorable; the
crew reported that operational performance of the fuel system and gas
turbine engines on the 50/50 blend was similar comparable to operations
on traditional petroleum F-76.
"The U.S. Navy continues to demonstrate the effectiveness of our fuel in
multiple vessels, and we are honored to have the opportunity to assist
with efforts to reduce their dependence on fossil fuels," said Rogerio
Manso, Chief Commercialization Officer, Solazyme. "We view these
successful tests as an important step towards the commercialization of
our renewable fuels."
Solazyme has successfully completed the delivery of over 500,000 liters
of in-specification fuel to the U.S. Navy including the largest
deliveries of microbially-derived advanced biofuels in history. In
December 2011, Dynamic Fuels, LLC, a joint venture between Tyson Foods,
Inc. (NYSE: TSN) and Syntroleum Corporation (NASDAQ: SYNM), announced it
had been awarded a contract to supply the U.S. Navy with 450,000 gallons
(1.7 million liters) of renewable fuels. Solazyme is partnered with
Dynamic Fuels to fulfill the contract, and delivery to the U.S. Navy is
scheduled for May 2012, marking the single largest purchase of advanced
biofuel in government history.
Solazyme's renewable diesel and jet fuels meet all of the EU, ASTM and
draft military specifications for diesel, marine diesel and jet biofuels.
About Solazyme, Inc.
Solazyme, Inc. (NASDAQ: SZYM) is a renewable oil and bioproducts company
that transforms a range of low-cost plant-based sugars into high-value
oils. Headquartered in South San Francisco, Solazyme's renewable
products can replace or enhance oils derived from the world's three
existing sources — petroleum, plants and animal fats. Initially,
Solazyme is focused on commercializing its products into three target
markets: (1) fuels and chemicals, (2) nutrition and (3) skin and
Solazyme®, the Solazyme logo and other trademarks or service names are
trademarks of Solazyme, Inc.
Forward Looking Statements
This press release contains certain forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of 1995
about Solazyme, including statements that involve risks and
uncertainties concerning: the commercialization of its renewable fuels
and the scheduled delivery date of fuel to the U.S. Navy. When used in
this press release, the words "will", "expects", "intends", "scheduled"
and other similar expressions and any other statements that are not
historical facts are intended to identify those assertions as
forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995. Any such statement may be influenced by a
variety of factors, many of which are beyond the control of Solazyme,
that could cause actual outcomes and results to be materially different
from those projected, described, expressed or implied in this press
release due to a number of risks and uncertainties. Potential risks and
uncertainties include, among others: Solazyme's limited history in
commercializing products; implementation risk in deploying new
technologies; and Solazyme's ability to maintain strategic
collaborations. Accordingly, no assurances can be given that any of the
events anticipated by the forward-looking statements will transpire or
occur, or if any of them do so, what impact they will have on the
results of operations or financial condition of Solazyme.
In addition, please refer to the documents that Solazyme, Inc. files
with the Securities and Exchange Commission, including its Quarterly
Report on Form 10-Q for the quarter ended September 30, 2011 for a
discussion of these and other risks. You are cautioned not to place
undue reliance on forward-looking statements, which speak only as of the
date of this press release. Solazyme is not under any duty to update any
of the information in this press release.
Genet Garamendi, 650-780-4777
VP of Communications
Source: Solazyme, Inc.
News Provided by Acquire Media